Come on in!
A new ORNL device controls the size and shape of ceramic particles to minimize defects in final products.
Four ORNL radiopharmaceutical agents are being tested in human patients with cancer, heart disease, or pancreatic insufficiency. Another is in preclinical testing for brain disorders like Alzheimer's disease.
A tumor-suppressor gene could help determine if waste-site chemicals pose a human cancer threat.
Two sidebars discuss the gene's potential for treating cancer and AIDS.
ORNL is helping develop better ways of isolating high-level and low-level radioactive wastes.
Take a Number--On letting computers make decisions
User Facilities--Building Envelope Research Center
Educational Activities--"Adventures in Supercomputing" for students; educational networks
R&D Updates - Part 1--Buckyballs in nature; fullerene structure probed by neutron scattering; stealthier submarine designs evaluated
R&D Updates - Part 2--Data base on forest growth in carbon dioxide-enriched atmosphere; sea-level rise and coastal species habitats; informatics and the human genome; pilot plant for wastewater treatment evaluation; DNA sequencing by laser
Technical Highlights--Sharpest direct images of atoms obtained by electron microscope; chemical analysis at the atomic level; ORNL codes run on 512-node supercomputer; neutron interrogation system for weapons verification; spectroelectrochemical sensor for environmental monitoring
Technology Transfer--Cooperative agreement for automated laser deposition of thin films; superconducting wire technology licensed; lightweight shielding for electronic components licensed